17β-HSD1 |
17β-hydroxysteroid dehydrogenases type 1 |
17β-HSD2 |
17β-hydroxysteroid dehydrogenases type 2 |
AR |
Androgen receptor |
ATM |
Ataxia telangiectasia mutated |
ATR |
Ataxia telangiectasia and Rad3 related |
BP |
Butylparaben |
BMI |
Body mass index |
BzP |
Benzylparaben |
CCND1 |
Cyclin D1 |
CCND3 |
Cyclin D3 |
CCNE1 |
Cyclin E1 |
CCNE2 |
Cyclin E2 |
CCNA2 |
Cyclin A2 |
CDK2 |
Cyclin Dependent Kinase 2 |
CDK4 |
Cyclin Dependent Kinase 4 |
CDK6 |
Cyclin Dependent Kinase 6 |
CDKN1A |
Cyclin Dependent Kinase Inhibitor 1A |
CYP19A1 |
cytochrome P450 19A1 (aromatase) |
DHT |
Dihydrotestosterone |
E2F3 |
Transcription factor E2F3 |
EEF |
Estradiol equivalence factor |
E1 |
Estrone |
E2 |
17β-estradiol |
ER |
Estrogen receptor |
EDCs |
Endocrine-disruptive chemicals |
EMT |
Epithelial-to-mesenchymal transitions |
EP |
Ethylparaben |
GPER |
G-protein-coupled estrogen receptor (GPR30 or GPER1) |
GR |
Glucocorticoid receptor |
HeP |
hexylparaben |
HepP |
Heptylparaben |
HER2 |
Human epidermal growth factor receptor 2 |
HRG |
Heregulin |
IsoBP |
Isobutylparaben |
IsoPP |
Isopropylparaben |
MMPs |
Matrix metalloproteinases |
MP |
Methylparaben |
PhP |
Phenylparaben |
PR |
Progesterone receptor |
PP |
Propylparaben |
TP53 |
Tumor protein p53 |